A CRISPR-Cas9-based allele-specific editing platform using a specific single guide-RNA (sgRNA) successfully edited a de novo c.475/495del21 mutation within exon 1 of the KRT14 gene in a dominant form of EBS. The gene discussed is KRT14; the disease is epidermolysis bullosa simplex.